Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute of Health (NIH) has awarded a Specialized Program of Research Excellence (SPORE) in Ovarian Cancer to MD Anderson Cancer Center, Houston Texas. 

The value of the award is $8.7 Million over 5 years. Congratulations to Professor Ahmed who is a co-investigator on one of three programs that are supported by this prestigious award. The program aims to test the therapeutic value of SIK2 inhibitors in ovarian cancer patients. 

Our research at the Nuffield Department of Obstetrics & Gynaecology explores the molecular mechanisms that drive Ovarian Cancer cell growth and examines which targeted therapies can be utilised to improve the treatment of women with Ovarian Cancer.

Read more about our research on Ovarian Cancer 

Ahmed Ahmed

Similar stories

Singula Bio provides new hope for cancer with diverse, individualised therapies

Cancer

The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.

Understanding the origins of ovarian cancer

Cancer

Research into the early detection of ovarian cancer by the Ahmed group, receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

MitOX 2017 - 1st December

Cancer Reproductive Medicine & Genetics Research

The Nuffield Department of Obstetrics & Gynaecology invites you to MitOX 2017 - an annual meeting with talks on mitochondrial genetics, physiology, neurosciences and cancer.

Cancer hijacks natural cell process to survive

Cancer

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by Professor Ahmed Ahmed at the Nuffield Department of Obstetrics & Gynaecology. This discovery could help clinicians identify and inhibit the process, giving them much better control of a person's cancer.

Cannabinoid biomedicine research programme launched

Cancer Research

Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.

Professor receives award for his work on ovarian cancer

Cancer Research

Professor Ahmed is seen here receiving an award for `International Scientist of the Year' from the United Arab Emirates Genetics Diseases Association (UAEGDA). The award was presented by His Royal Highness Sheikh Nahyan Al Nahyan, UAE Minister of Youth and Culture.